Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline in COPD Patients on Long-acting Bronchodilators
NCT00299858Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Oct 2006
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of theophylline in chronic obstructive pulmonary disease (COPD), sponsored by Ottawa Hospital Research Institute. Started Oct 2006; status: completed.
02
Drugs
theophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00299858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299858.